BioNexus Gene Lab Corp — Quarterly Financial Statistics (NASDAQ:BGLC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 78.2 K-824.07 K-737.91 K-1.24 M961.06 K -1.84 M Cash from investing activities 554.4 K-15.65 K-28.53 K994.65 K-5 717 944.75 K Cash from financing activities -1 387-860-1 03034.19 K266.54 K 298.84 K Free cash flow 74.18 K-833.12 K-759.37 K-1.24 M960.09 K -1.88 M

News

BioNexus Gene Lab appoints commercial officer at Fidelion

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform

BioNexus Gene Lab stock soars after strategic MRD testing agreements

BioNexus Gene Lab files $100 million shelf registration, launches ATM program

BioNexus Gene Lab enters strategic partnership talks with BirchBioMed

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.38%

US Stocks Edge Higher; Kraft Heinz Earnings Top Views - BioNexus Gene Lab (NASDAQ:BGLC), Kraft Heinz (NASDAQ:KHC)

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - BioNexus Gene Lab (NASDAQ:BGLC), 180 Life Sciences (NASDAQ:ATNF)